After Olmesartan Lipids Hydrochlorothiazide and Benildipine Hydrochloride tablets are finished, you can’t switch to Chlordiazepoxide Benzenesulfonate tablets. Olmesartan Lipid Hydrochlorothiazide is a compound preparation containing two antihypertensive drugs, which can reduce the extracellular volume and lower the peripheral vascular resistance after taking it, thus exerting the effect of lowering blood pressure, and is mainly used in the treatment of hypertension. Olmesartan Lipid Hydrochlorothiazide may cause dizziness, headache, vomiting and other discomforts after taking it. And it is contraindicated in people who are allergic to the components of the drug. Blood pressure, liver and kidney functions should be monitored during the course of medication, and pregnant and lactating women should use the drug under the guidance of a doctor. Benildipine hydrochloride tablets and amlodipine benzenesulfonate tablets belong to the dihydropyridine class of calcium antagonists, after taking can reduce the extracellular calcium ions into the vascular smooth muscle cells, so as to play a role in lowering blood pressure, is mainly used in the treatment of primary hypertension, angina pectoris and other diseases. Benildipine Hydrochloride Tablets and Amlodipine Benzenesulfonate Tablets may cause dizziness, headache and other discomforts after taking. And it is forbidden for those who are allergic to the components of the drug and those who are in cardiogenic shock. Blood pressure, liver and kidney functions should be monitored during the course of medication, and pregnant and lactating women should use the drug under the supervision of a doctor. Olmesartan Lipohydrochlorothiazide Tablets belong to the compound preparation, and when taken with Benidipine Hydrochloride Tablets belong to the combined treatment program of three antihypertensive drugs, which has a strong antihypertensive effect and a long antihypertensive time. Replacement with amlodipine benzenesulfonate tablets may result in a weakening of the antihypertensive effect to the detriment of blood pressure control. If there is a need to adjust the medication regimen, it is recommended to consult the cardiovascular medicine department in a timely manner, and the decision will be made after the doctor’s comprehensive assessment of the condition.